VitaK BV / Maastricht University Medical Center
Maastricht, 6229 EV, Netherlands
NCT Number: NCT01873274
The objective of this study is to investigate the absorption of menaquinone-7 from a nutrient-enriched dairy product compared to a general dairy product enriched with menaquinone-7 and a menaquinone-7-containing supplement.
Looking for future studies?
Notify Me45 year–65 year
All sexes
Interventional
Not applicable
Maastricht, 6229 EV, Netherlands
In an earlier study, beneficial effects of a nutrient-enriched dairy product on vitamin K-status were observed. The study product contained menaquinone-7 (MK-7) and omega-3 fatty acids for vascular health and extra minerals and antioxidants to support general health. It was the first time that such low dose of MK-7 (50 µg) could significantly improve vascular and general vitamin K-status already after short-term treatment. From the results of this study, it was assumed that the matrix of the dairy product and/or other components in the product, in which the vitamin was offered, contributed to optimal absorption and availability of vitamin K2. In this new study, the uptake and efficacy of MK-7 from the nutrient enriched product is investigated and compared to the uptake and efficacy from a MK-7-containing supplement and a basic dairy product enriched with MK-7.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline and 6 weeks
Time frame: baseline and 6 weeks
Time frame: baseline and 6 weeks
Maastricht University Medical Center
Other
Comparative Study of Three Delivery Systems of Menaquinone-7
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07345130
Bioavailability, Bioequivalence
Las Vegas, Nevada, United States
View Trial DetailsNCT06481709
Bioavailability
Toronto, Ontario, Canada
View Trial DetailsNCT05263895
Bioavailability, COVID-19
New Haven, Connecticut, United States
View Trial DetailsNCT05627518
Bioavailability, Pharmacokinetics
Ljubljana, Ukmarjeva Ulica 6, Slovenia
View Trial Details